Modelos europeos de telemedicina, como el servicio finlandés Medilux, permiten realizar consultas médicas online mediante un cuestionario clínico, sin acudir a una consulta presencial.

Left or Right Transradial Approach? Comparing Radiation Exposure in Coronary Procedures

Radiation exposure during percutaneous procedures is a problem both for patients and operators. The transradial is currently the preferred approach, vs. femoral; however, whether the left (LRA) or right (RRA) approach is associated to lower radiation burden remains controversial. This meta-analysis aimed at systematically comparing radiation exposure between these two during diagnostic and therapeutic coronary procedures. 

The primary outcome was difference in fluoroscopy time (FT) and dose-area product (DAP) between LRA and RRA. Secondary outcomes included cumulative air kerma (CAK) and operator radiation exposure, assessed as absolute dose and DAP thorax dose.

There was a systematic review following PRISMA recommendations, including randomized clinical trials published until July 2025. 19 studies were looked at, with total 9,443 patients undergoing coronary angiogram/ and or percutaneous coronary intervention. 4,584 of these patients were treated with RRA and 4,607 with LRA. These trials were conducted in Asia, Europe, and North America, and included operators with different expertise. 

Outcomes showed LRA was associated with a statistically significant fluoroscopy time vs. RRA (standardized mean difference [SMD] 0.105, 95% confidence interval: 0.037-0.174, p = 0.003). Also, DAP resulted significantly lower with LRA vs. RRA (SMD 0.09, 95% CI: 0.016-0.163, p = 0.017). 

Read also: Dual Antiplatelet Therapy in Diabetic Patients with AMI: De-Escalation Strategy.

In contrast, there were no significant differences in cumulative air kerma (CAK) between groups (SMD 0.067, 95% CI: -0.001 to 0.135, p = 0.055). As regards operator radiation exposure, LRA was associated with significant reduction both of absolute and DAP normalized thorax doses (SMD 0.297, 95% CI: 0.023-0.71, p = 0.034; SMD 0.392, 95% CI: 0.251-0.533, p = 0.000, respectively). 

Conclusion

This meta-analysis shows the LRA is associated with lower fluoroscopy time, DAP and operator radiation exposure vs RRA during percutaneous coronary procedures, with no significant difference in CAK. These findings support LRA as a potentially safer strategy as to radiation exposure. 

Original Title: Comparison of Radiation Exposure to X-Ray Between Left and Right Radial Approach During Coronary Procedures: A Meta-Analysis Based on Randomized Controlled Trials.

Reference: Youjin Zhu, et al. Department of Cardiovascular Medicine, Institute of Cardiovascular Disease, Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China. Catheterization and Cardiovascular Interventions, 2025.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

Más artículos de este Autor

EuroPCR 2026 | 10-Year Left Main PCI: When Survival Is Similar, Should the Less Invasive Strategy Prevail?

The primary goal of revascularization in left main coronary artery disease (LMCA) is to improve survival. However, debate continues regarding whether, in anatomically suitable...

EuroPCR 2026 | TAVI and Coronary Artery Disease: FFR-Guided PCI Showed Better Outcomes Than an Angiography-Guided Strategy

In patients undergoing TAVI, the concomitant presence of coronary artery disease continues to generate debate: whether coronary lesions should be treated before, during, or...

EuroPCR 2026 | Evolocumab Reduces Cardiovascular Events in Patients With Prior PCI Without Previous Myocardial Infarction: VESALIUS-CV Results

This presentation, delivered by Dr. Brian A. Bergmark and colleagues at EuroPCR 2026, detailed the results of the VESALIUS-CV trial, focusing specifically on the...

EuroPCR 2026 | Is It Safe to Stop Aspirin After One Month in MI Patients Undergoing PCI? TARGET-FIRST Analysis

This is a summary of the post-hoc analysis of the TARGET-FIRST study, presented by Dr. Giuseppe Tarantini at EuroPCR 2026, evaluating early aspirin discontinuation...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Artículos relacionados

Jornadas Guatemala 2026
Jornadas SOLACIspot_img

Artículos recientes

06/03 | SOLACI Technicians & Nurses Webinar – Clinical Impact of Structural Interventions: TAVI and MitraClip in Current Practice

The Latin American Society of Interventional Cardiology (SOLACI), through its Technicians and Nurses Department, invites you to participate in a new scientific webinar entitled...

EuroPCR 2026 | TAVI in Women: Do Supra-Annular Valves Offer a True Hemodynamic Advantage?

Women represent a particularly challenging population for TAVI, as they often have smaller aortic annuli, greater frailty, and an increased risk of prosthesis-patient mismatch....

EuroPCR 2026 | TAVI or Surgery in Younger Patients? Quality of Life and 3-Year Outcomes from NOTION-2

The expansion of TAVI into younger and lower surgical-risk populations has sparked a new debate: beyond mortality and stroke, which strategy provides better functional...